#versanis — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #versanis, aggregated by home.social.
-
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/ -
Expect a renewed big push for obesity treatments. Lots of money riding on these therapies!
Eli #Lilly will pay up to $1.9 billion to acquire biotech #Versanis for it’s Phase II #Obesity candidate #Bimagrumab, a #MonoclonalAntibody that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II trials both as a standalone drug and in combination with the anti-#diabetes peptide #semaglutide.
#Wegovy #Mounjaro #ozempic #weightloss
https://bioprocessintl.com/bioprocess-insider/deal-making/lilly-going-bigger-on-obesity-with-versanis-buy/